Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy.

MLA

Nöpel-Dünnebacke, S., et al. “Prognostic Value of Microsatellite Instability and P53 Expression in Metastatic Colorectal Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Chemotherapy.” Zeitschrift Für Gastroenterologie, vol. 52, no. 12, Dec. 2014, pp. 1394–401. EBSCOhost, https://doi.org/10.1055/s-0034-1366781.

APA

Nöpel-Dünnebacke, S., Schulmann, K., Reinacher-Schick, A., Porschen, R., Schmiegel, W., Tannapfel, A., & Graeven, U. (2014). Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy. Zeitschrift Für Gastroenterologie, 52(12), 1394–1401. https://doi.org/10.1055/s-0034-1366781

Chicago

Nöpel-Dünnebacke, S., K. Schulmann, A. Reinacher-Schick, R. Porschen, W. Schmiegel, A. Tannapfel, and U. Graeven. 2014. “Prognostic Value of Microsatellite Instability and P53 Expression in Metastatic Colorectal Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Chemotherapy.” Zeitschrift Für Gastroenterologie 52 (12): 1394–1401. doi:10.1055/s-0034-1366781.